TYROSINE KINASE INHIBITOR
Clinical trials for TYROSINE KINASE INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new TYROSINE KINASE INHIBITOR trials appear
Sign up with your email to follow new studies for TYROSINE KINASE INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Simple smell and taste exercises may bring flavor back to cancer patients' meals
Symptom relief Recruiting nowThis study tests whether a 12-week at-home taste and smell training program can improve taste function in cancer patients who experience taste changes from tyrosine kinase inhibitors. Ninety participants across 12 Dutch hospitals will be randomly assigned to the training or stand…
Matched conditions: TYROSINE KINASE INHIBITOR
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Could a lifesaving leukemia drug harm Men's sexual health?
Knowledge-focused Recruiting nowThis study looks at whether tyrosine kinase inhibitors (TKIs), the standard treatment for chronic myeloid leukemia (CML), might be linked to erectile dysfunction (ED) in men. Researchers will track 350 male patients who started TKI therapy, using questionnaires and medical record…
Matched conditions: TYROSINE KINASE INHIBITOR
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC